BNP Paribas Financial Markets
ZYME icon

BNP Paribas Financial Markets’s Zymeworks ZYME Stock Holding History

BNP Paribas Financial Markets’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$704K Buy
28,119
+4,821
+21% +$114K ﹤0.01% 3388
2025
Q4 		$613K Buy
23,298
+7,838
+51% +$171K ﹤0.01% 3457
2025
Q3 		$264K Buy
15,460
+5,153
+50% +$73.8K ﹤0.01% 3877
2025
Q2 		$129K Buy
10,307
+6,307
+158% +$75.1K ﹤0.01% 3930
2025
Q1 		$47.6K Sell
4,000
-3,363
-46% -$45.9K ﹤0.01% 4304
2024
Q4 		$108K Buy
+7,363
New +$103K ﹤0.01% 4140
2022
Q2 		– Sell
-286,928
Closed -$1.88M – 4283
2022
Q1 		$1.88M Buy
286,928
+177,647
+163% +$1.58M ﹤0.01% 1864
2021
Q4 		$1.79M Buy
109,281
+108,584
+15,579% +$2.26M ﹤0.01% 2135
2021
Q3 		$20.2K Buy
697
+55
+9% +$1.83K ﹤0.01% 3638
2021
Q2 		$22.3K Buy
642
+290
+82% +$9.2K ﹤0.01% 3508
2021
Q1 		$11.1K Buy
352
+279
+382% +$11.3K ﹤0.01% 3823
2020
Q4 		$3.45K Buy
+73
New +$3.39K ﹤0.01% 3980

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BNP Paribas Financial Markets's ZYME Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Zymeworks (ZYME) stake by 21% in Q1 2026, buying an estimated $114K and bringing the position to 28,119 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #3388.

BNP Paribas Financial Markets first reported a position in ZYME in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.88M in Q1 2022. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • BNP Paribas Financial Markets held 28,119 shares of Zymeworks worth $704K as of Q1 2026.
  • BNP Paribas Financial Markets bought 4,821 Zymeworks shares in Q1 2026, an estimated $114K.
  • Zymeworks made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3388 holding.
  • BNP Paribas Financial Markets first reported a position in Zymeworks in Q4 2020 and has held it in 12 quarters since.
  • BNP Paribas Financial Markets's Zymeworks position peaked at $1.88M in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.